Economic burden of recurrent venous thromboembolism: Analysis from a U.S. hospital perspective.
Purpose. An analysis of resource utilization and hospital costs associated with recurrent venous thromboembolism (VTE) is presented. Methods. A retrospective cohort analysis was conducted using a large U.S. hospital database. Patients with VTE-related hospitalization events during the period January...
| Publicado en: | American Journal of Health-System Pharmacy Vol. 72; no. 4; pp. 291 - 301 |
|---|---|
| Autores principales: | , , , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
Oxford University Press / USA
2/15/2015
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=103749752&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 103749752 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 10792082 1X3 jtl: American Journal of Health-System Pharmacy issn: 10792082 maglogo: N pubinfo: dt: 2/15/2015 vid: 72 iid: 4 pid: 622 pub: Oxford University Press / USA artinfo: ui: 103749752 100787782 10.2146/ajhp140204 NLM25631836 103749752 ppf: 291 ppct: 10 formats: fmt: @attributes: type: P tig: atl: Economic burden of recurrent venous thromboembolism: Analysis from a U.S. hospital perspective. aug: au: Casciano, Julian P. Dotiwala, Zenobia Kemp, Robert Chenghui Li Cai, Jennifer Preblick, Ronald affil: President and CEO, eMAX Health Systems, LLC, White Plains, NY sug: subj: Venous Thromboembolism Drug Therapy Recurrence Economics Health Facility Costs Length of Stay United States Human Retrospective Design Prospective Studies Descriptive Statistics Data Analysis Software Funding Source Male Female Adult Middle Age Aged Aged, 80 and Over Health Resource Utilization Adult: 19-44 years Middle Aged: 45-64 years Aged: 65+ years Aged, 80 & over Male Female ab: Purpose. An analysis of resource utilization and hospital costs associated with recurrent venous thromboembolism (VTE) is presented. Methods. A retrospective cohort analysis was conducted using a large U.S. hospital database. Patients with VTE-related hospitalization events during the period January–December 2010 were identified; data collection extended for up to 12 months after the index event. Postdischarge hospital resource use and total costs were compared in cohorts of patients with and without recurrent VTE. Regression analysis was performed to compare hospital costs and length of stay (LOS) during initial and subsequent VTE encounters. Results. Among the study population of 43,734 patients, 4% had postdischarge VTE-related events during the data collection period. The median and mean ± S.D times to VTE recurrence were 48 days and 98 ± 106 days, respectively. Patients with recurrent VTE had more all-cause hospitalizations than those without recurrent VTE (mean ± S.D., 1.07 ± 0.96 versus 0.15 ± 0.53; p < 0.0001), more all-cause emergency room visits (mean ± S.D., 0.31 ± 0.66 versus 0.05 ± 0.31; p < 0.0001), and greater total costs (mean ± S.D., $28,353 ± $39,624 versus $17,712 ± $33,461; p < 0.0001). Relative to initial VTE admissions, admissions for recurrent VTE were, on average, associated with a 14% longer LOS (p = 0.0002) and a 22% higher total cost (p < 0.001). Conclusion. Patients with recurrent VTE used more hospital resources than those without recurrent VTE. Readmissions for VTE were significantly longer and more costly than index encounters. pubtype: Academic Journal doctype: research tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|